Pulmonary heart disease, medically termed cor pulmonale, manifests as a condition marked by the enlargement and impaired function of the right ventricle of the heart. Unlike diseases originating in the left side of the heart, pulmonary heart disease is primarily driven by elevated pressure in the pulmonary arteries. These vessels play a vital role in transporting blood from the heart to the lungs for oxygenation. The genesis of pulmonary heart disease often lies in prolonged instances of heightened blood pressure within the pulmonary arteries. This heightened pressure is frequently a consequence of underlying chronic respiratory ailments such as chronic obstructive pulmonary disease (COPD), pulmonary hypertension, and various interstitial lung diseases. The persistent strain on the pulmonary circulation prompts the right ventricle to intensify its pumping efforts, leading to enlargement and, potentially, eventual failure.
Title : Revolutionizing CKD care: How finerenone transforms outcomes in heart and kidney health - Insights from fidelio-DKD
Robert J Chilton, University of Texas Health Science Center San Antonio, United States
Title : Novel important cellular responses, signaling mechanisms and therapeutic options for pulmonary hypertension and right heart failure
Yong Xiao Wang, Albany Medical Center, United States
Title : Preventing sports-related cardiac arrest: Coronary artery calcium scoring stratifies the benefit of low-dose aspirin use for risk reduction
Arthur J Siegel, Massachusetts General Hospital, United States
Title : TED2HOME - A low cost automatic external defibrillator for home/office
Abraham Teddy Weiss, Hadassah University Hospital, Israel
Title : Subclinical atherosclerosis: Association with additional risk factors and somatic diseases
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain